5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression

Keyphrases

• HPV16 100%
• MiR-375 100%
• HPV16 E7 100%
• Long Control Region 50%
• E6 Gene 50%
• High-risk Human Papillomavirus (HR-HPV) 25%
• Cervical Cancer 25%
• Genotype 25%
• Etiological Agents 25%
• Host Cell 25%
• Gene Regulation 25%
• Overexpression 25%
• Upstream Open Reading Frame (uORF) 25%
• Infected Cells 25%
• Protein Level 25%
• MRNA Level 25%
• Transcription Factor 25%
• Oncogenesis 25%
• Transcriptional Repressor 25%
• Viral Oncoproteins 25%
• 5-aza-2′-deoxycytidine 25%
• E7 Oncoprotein 25%
• E6 Oncoprotein 25%
• DNA Methylation (DNAm) 25%
• Epigenetic Mechanisms 25%
• HPV-related Cancers 25%
• Early Genes 25%
• High-risk HPV 25%
• Decreased Expression 25%
• Early Gene Expression 25%
• Splicing Pattern 25%
• Epigenetic Events 25%
• HPV Integration 25%
• SiHa Cells 25%
• Demethylate 25%
• E7 Expression 25%
• RNA Splicing 25%
• Cellular DNA 25%
• Immortalization 25%
• Methylation 25%
• E6 Protein 25%
• Viral mRNA 25%

Biochemistry, Genetics and Molecular Biology

• Human Papillomavirus Type 16 100%
• Messenger RNA 40%
• Carcinogenesis 40%
• Wart Virus 20%
• Genotyping 20%
• Gene Expression 20%
• Gene Control 20%
• Promoter Region 20%
• Open Reading Frame 20%
• Transcription Factor 20%
• Epigenetics 20%
• P97 20%
• Transcriptional Repressor 20%
• Methylation 20%
• Decitabine 20%
• DNA Methylation 20%
• Upregulation 20%
• DNA Integration 20%
• Epigenetic Mechanism 20%
• RNA Splicing 20%

Immunology and Microbiology

• Human Papillomavirus Type 16 100%
• Wart Virus 20%
• Gene Expression 20%
• Host Cell 20%
• Cell Line 20%
• Transcription Factor 20%
• Open Reading Frame 20%
• Promoter Region 20%
• Repressor Gene 20%
• Upregulation 20%
• Methylation 20%
• Epigenetic Mechanism 20%
• RNA Splicing 20%
• DNA Integration 20%
• DNA Methylation 20%
• Gene Control 20%